Anti-Cleaved Caspase-3 antibody
4
(57 Reviews)
|
(1676 Publications)
Anti-Cleaved Caspase-3 antibody (ab2302) is a rabbit polyclonal antibody detecting Cleaved Caspase-3 in Western Blot. Suitable for Human.
- Over 1360 publications
- Trusted since 2003
View Alternative Names
CPP32, CASP3, Caspase-3, CASP-3, Apopain, Cysteine protease CPP32, Protein Yama, SREBP cleavage activity 1, CPP-32, SCA-1
- WB
Lab
Western blot - Anti-Cleaved Caspase-3 antibody (AB2302)
All lanes:
Western blot - Anti-Cleaved Caspase-3 antibody (ab2302) at 1 µg/mL
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate (2 uM Staurosporine, 4Hr) at 20 µg
Lane 2:
HeLa whole cell lysate (untreated) at 20 µg
Lane 3:
Cleaved Caspase 3 (recombinant protein) at 0.1 µg
Secondary
All lanes:
800CW Goat Anti-Rabbit IgG at 1/10000 dilution
Predicted band size: 32 kDa
Observed band size: 17 kDa,24 kDa,35 kDa
false
- WB
Unknown
Western blot - Anti-Cleaved Caspase-3 antibody (AB2302)
All lanes:
Western blot - Anti-Cleaved Caspase-3 antibody (ab2302) at 1 µg/mL
All lanes:
Camptothecin (2 µM) treated Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate
Predicted band size: 32 kDa
false
- WB
Supplier Data
Western blot - Anti-Cleaved Caspase-3 antibody (AB2302)
All lanes:
Western blot - Anti-Cleaved Caspase-3 antibody (ab2302)
Lane 1:
Untreated Jurkat cell line (human T cell leukemia cell line from peripheral blood) at 60 µg
Lane 2:
Camptothecin treated Jurkat cell line (human T cell leukemia cell line from peripheral blood) at 60 µg
Predicted band size: 32 kDa
false
- WB
AbReview80460****
Western blot - Anti-Cleaved Caspase-3 antibody (AB2302)
All lanes:
Western blot - Anti-Cleaved Caspase-3 antibody (ab2302) at 1/2000 dilution
All lanes:
Poly I:C treated Melanoma cells at 20 µg
Secondary
All lanes:
Goat anti-rabbit IgG (HRP) at 1/1000 dilution
false
This image is courtesy of an anonymous Abreview
Reactivity data
Product details
Product Specifications
Anti-Cleaved Caspase-3 antibody (ab2302) is a rabbit polyclonal antibody and is validated for use in WB in human, recombinant fragment samples.
Anti-Cleaved Caspase-3 antibody (ab2302) specifically detects Cleaved Caspase-3 (UniProt ID: P42574; Molecular weight: 17kDa) and is sold in 50 µg selling sizes.
Quality and Validation
Abcam's high quality validation processes ensure Anti-Cleaved Caspase-3 antibody (ab2302) has high sensitivity and specificity.
Anti-Cleaved Caspase-3 antibody (ab2302) has been cited over 1368 times in peer reviewed journals and is trusted by the scientific community.
Anti-Cleaved Caspase-3 antibody (ab2302) has 55 independent reviews from customers.
Target Information
Cleaved Caspase-3 is a crucial marker of apoptosis, the programmed cell death process. It is the activated form of Caspase-3, resulting from proteolytic cleavage. Cleaved Caspase-3 plays a vital role in executing apoptosis by cleaving various cellular substrates, leading to cell dismantling. Researchers use Cleaved Caspase-3 as a reliable indicator of apoptosis in studies of cancer, neurodegenerative diseases, and other conditions involving cell death. Its detection is essential for understanding the mechanisms of apoptosis and developing targeted therapies. In cancer research, cleaved Caspase-3 is used to assess the effectiveness of anti-cancer therapies that induce apoptosis in tumor cells. Elevated levels of cleaved Caspase-3 have been associated with better prognosis in certain cancers, such as oral tongue squamous cell carcinoma. Additionally, cleaved Caspase-3 has been implicated in non-apoptotic roles, such as promoting angiogenesis and chemotherapy resistance. Neurodegenerative Diseases: In neurodegenerative diseases like Alzheimer's (AD) and Parkinson's (PD) disease, cleaved Caspase-3 is involved in the apoptotic pathways that lead to neuronal cell death. For instance, caspase-3-cleaved Tau aggregates more easily than full-length Tau, contributing to the pathology of Alzheimer's disease. Understanding the role of cleaved Caspase-3 in these diseases helps researchers develop targeted therapies to mitigate neuronal loss and disease progression.
This product is manufactured by BioVision, an Abcam company and was previously called 3015 Anti-Caspase-3 (Active) Polyclonal Antibody.
Caspases are synthesized as inactive pro-enzymes that are processed to active form in cells undergoing apoptosis. Caspase 3 has been extensively studied and implicated to play an important role in apoptosis. Active caspase 3 proteolytically cleaves and activates other caspases, as well as relevant targets in the cells (e.g., PARP). This affinity purified antibody recognizing the active forms of caspase-3 provides a new tool for identifying apoptotic cell populations in both tissue sections and cultured cells.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Caspase 3 acts as an executioner enzyme in the process of programmed cell death. Its cleavage from the inactive zymogen form into the active form triggers apoptotic pathways ensuring the removal of damaged or unnecessary cells. Cleaved caspase operates within a proteolytic cascade often in conjunction with other caspases such as caspase 9. Once activated caspase 3 targets and cleaves specific cellular substrates contributing to the characteristic morphological changes and DNA fragmentation associated with apoptosis.
Pathways
Cleaved caspase 3 is significant within the intrinsic and extrinsic apoptotic pathways. It acts downstream of initiator caspases such as caspase 9 in the intrinsic pathway where its activation involves mitochondrial signals. In the extrinsic pathway it closely associates with caspase 8 mediating cell death signals from extracellular triggers. These pathways ensure that cleaved caspase 3 fulfills its role as a critical mediator of apoptosis linking upstream death signals to cellular dismantling during the apoptosis process.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1676)
Recent publications for all applications. Explore the full list and refine your search
The Tohoku journal of experimental medicine : PubMed41062301
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:697 PubMed41053036
2025
Applications
Unspecified application
Species
Unspecified reactive species
International heart journal 66:862-873 PubMed41034031
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:33132 PubMed41006689
2025
Applications
Unspecified application
Species
Unspecified reactive species
Radiology and oncology 59:349-367 PubMed40959921
2025
Applications
Unspecified application
Species
Unspecified reactive species
Degenerative neurological and neuromuscular disease 15:81-94 PubMed40937143
2025
Applications
Unspecified application
Species
Unspecified reactive species
General physiology and biophysics 44:429-438 PubMed40923661
2025
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 17:5332-5343 PubMed40821094
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of food and drug analysis 33:172-178 PubMed40592335
2025
Applications
Unspecified application
Species
Unspecified reactive species
Korean journal of anesthesiology : PubMed40590087
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com